Malta - inglês - Malta Medicines Authority

boehringer ingelheim limited - hyoscine butylbromide 10 mg - coated tablet

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi consumer healthcare - hyoscine butylbromide - oral tablet - 10mg

Malta - inglês - Malta Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - hyoscine butylbromide - coated tablet - hyoscine butylbromide 10 milligram(s) - drugs for functional gastrointestinal disorders

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 20 mg/ml - solution for injection - 20 mg/ml - active: hyoscine butylbromide 20 mg/ml excipient: sodium chloride water for injection

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -

Estados Unidos - inglês - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine - unii:2z3e1of81v) - butylscopolamine bromide 20 mg in 1 ml - buscopan is indicated for the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions in horses. buscopan should not be used in impaction colics associated with ileus, or in horses with glaucoma.

Canadá - inglês - Health Canada

sanofi consumer health inc - hyoscine butylbromide - tablet - 10mg - hyoscine butylbromide 10mg - antimuscarinics antispasmodics

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - hyoscine butylbromide -

Canadá - inglês - Health Canada

church & dwight canada corp - dimenhydrinate - tablet - 50mg - dimenhydrinate 50mg - antihistamines